Dongyang Pharmaceutical said that its self-developed Tokumendong double insulin was approved for marketing to treat type 2 diabetes in adults. Dongyang Pharmaceutical became the second domestic pharmaceutical company to be approved for this type, and the number of insulin approved domestically increased to 7.

Zhitongcaijing · 2d ago
Dongyang Pharmaceutical said that its self-developed Tokumendong double insulin was approved for marketing to treat type 2 diabetes in adults. Dongyang Pharmaceutical became the second domestic pharmaceutical company to be approved for this type, and the number of insulin approved domestically increased to 7.